Over the past few seasons, there have been more and more cases involving players abusing the NFL's performance-enhancing drug policy. The New York Giants' Michael Thomas wants “less gray area” in the policy amid Golden Tate's suspension.
The Giants veteran safety is a Vice President of the NFL Executive Board. Thomas believes there should be changes made to the policy in the next Collective Bargaining Agreement—that is currently being negotiated.
Near the start of training camp, Tate is facing a four-game suspension for violating the NFL's PED policy. However, Tate believes he has a case in his appeal as he says he had a positive test due to a fertility drug he took earlier this year.
The NFL currently has a zero-tolerance policy when it comes to PEDs. Thomas, Tate's teammate, believes that there should be exceptions depending on the situation.
“Obviously you want to keep trying to improve it and figure out what are the special cases,” Thomas said. “Especially first-time cases. If someone has complied with everything as communicated, it’s still kind of no fault. But, I think there should be exceptions.”
Losing Tate would be detrimental to the Giants as the team is already expecting Sterling Shepard to miss some time with a fractured thumb he suffered at the beginning of training camp. Along with Shepard, Corey Coleman also tore his ACL during practice, making the receiver position thin for New York.
Currently, the Giants will head into Week 1 of the regular season with Bennie Fowler, Cody Latimer, and Russell Shepard as their top wide receivers.
Follow Us
Subscribe